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CARDIOVASCULAR MEDICINE
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Objectives: To determine potential interactions between the heart and arterial system in patients with
b thalassaemia major.
Design and patients: Vascular compliance, systemic vascular resistance, and left ventricular (LV)
contractility was determined in 34 asymptomatic thalassaemia patients at 2–4 hours after blood
transfusion and also in 34 age and sex matched controls using a non-invasive device. The results were
compared between groups and inter-relationships between LV contractility and indices of vascular load
were explored.
Setting: Tertiary paediatric cardiac centre.
Results: When compared with controls, patients had greater systemic vascular resistance (1633 (259) v
1377 (276) dynes/s/cm5, p , 0.001) and effective arterial elastance (Ea) (1.86 (0.25) v 1.65
(0.29) mm Hg/ml, p = 0.001), an index of combined pulsatile and static vascular load. On the other
hand, their systolic blood pressure (104 (9) v 112 (13) mm Hg, p = 0.006), pulse pressure (45 (9) v 57
(10) mm Hg, p , 0.001), adjusted systemic vascular compliance (1.21 (0.09) v 1.37 (0.14), p , 0.001),
adjusted brachial artery distensibility (21 (0.29) v 7.95 (0.29)%/mm Hg, p , 0.001) and LV+dP/dt
(1059 (183) v 1239 (237) mm Hg/s, p = 0.001) were significantly lower. Significant determinants of LV
contractility, as reflected by LV+dP/dt, were age (standardised b = 20.24, p = 0.003), body mass
index (standardised b = 20.34, p = 0.004), systolic blood pressure (standardised b = 0.90,
p , 0.001), and effective Ea (standardised b = 20.50, p , 0.001) (model R
2 = 0.69). No significant
correlation existed between serum ferritin concentration and any of the cardiac or vascular indices.
Conclusion: An unfavourable ventriculo-vascular interaction, as characterised by impaired cardiac
contractility and increased static and pulsatile vascular load, occurs in patients with b thalassaemia major.
A
bnormalities of left ventricular (LV) function are well
documented in patients with b thalassaemia major.1 2
In those with symptomatic heart failure, reduced LV
shortening and ejection fractions are evident. Even in
clinically asymptomatic patients, LV contractile dysfunction
has been unmasked by dobutamine infusion.3 While myo-
cardial iron deposition4 and myocarditis5 have a definite role
in the pathogenesis of cardiac dysfunction, arterial dysfunc-
tion has also recently been shown by our group to be
contributory.6
The relevance of arterial dysfunction becomes obvious
when the heart and arterial system are considered from a
mechanical perspective. Our finding of an increase in arterial
stiffness in patients with b thalassaemia major,6 which is
probably related to structural alteration7 8 and endothelial
dysfunction, suggests an increase in input impedance, and
hence the arterial load, that is presented to the left ventricle.
To date, however, no studies have been performed to
determine potential interactions between the heart and
arterial system in these patients. This in part may be related
to the need for invasive assessment of ventriculo-arterial
coupling by cardiac catheterisation.9 Recently, a non-invasive
technology has been developed that allows estimation of the
peak rate of positive LV pressure change (LV+dP/dt) and
derivation of vascular compliance and resistance (Dynapulse,
Pulse Metric, Inc, San Diego, California).10
Using this non-invasive technique, we determined the
vascular compliance, systemic vascular resistance, and
LV+dP/dt, an index of LV contractility, simultaneously in
clinically asymptomatic patients with b thalassaemia major
and compared the results to those of age and sex matched
control subjects. We further determined the interrelations
between LV contractility and indices of vascular load in
patients and controls.
METHODS
Subjects
Patients with b thalassaemia major were recruited from the
haematology clinic of Queen Mary Hospital. All of the
recruited patients had normal LV shortening fraction and
absence of valvar incompetence as documented by serial
echocardiographic studies. Smokers and those with heart
failure, systemic hypertension, and diabetes mellitus were
excluded. None of the patients were on vasoactive medica-
tions at the time of the study. Healthy subjects matched for
age and sex were recruited as controls. All subjects gave
informed consent.
For thalassaemia patients, the study was performed at 2–4
hours after blood transfusion, so as to minimise the
potentially confounding influence of anaemia and acute
volume loading on the assessment results. Body weight and
height were measured and the body surface area was
calculated accordingly. In patients, the mean serum ferritin
concentration was derived by averaging six to eight values
obtained approximately every two months for 12 months.
Non-invasive assessment of arterial pressure and
vascular compliance
Non-invasive arterial pressure signals were obtained with a
Dynapulse 5200A instrument interfaced to a personal
computer. The device records oscillometric pressure wave-
form signals from the brachial artery using an appropriately
sized pressure cuff that was wrapped around the right
upper arm. This technology uses a pulse dynamic pattern
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recognition methodology.10 The oscillometric signal is created
by coupling pressure changes in the brachial artery to
pressure changes in the cuff sphygmomanometer. As the
cuff deflates from supra-systolic and sub-diastolic pressure, a
silicon membrane pressure transducer produces an electric
signal, which is then digitised using an 8-bit A/D converter
for storage and analysis. The signals were stored in the hard
disk of the personal computer and analysed offline using an
automated system (Pulse Metric Inc) to derive the various
cardiac and systemic vascular parameters. Three recordings
were obtained from each of the subjects after at least 15
minutes of rest in the seated position, and the average was
calculated for subsequent analyses.
Cardiac parameters
The cardiac output was calculated using proprietary algo-
rithms and a model based on LV+dP/dt, heart rate, and
empirically derived scaling factors. The cardiac index was
calculated as cardiac output/body surface area, and the stroke
volume as cardiac output/heart rate.
The LV+dP/dt was derived from the arterial+dP/dt11
assuming Gaussian curves for both aortic and LV wave
contours. This method has been validated with simultaneous
measurements using invasive micromanometer tipped cathe-
ters in both normal subjects and patients with myocardial
infarction (r = 0.75 at baseline, r = 0.93 with inotropes).12
Vascular parameters
The systolic and diastolic blood pressures were determined
using standard oscillometric algorithms which have been
shown to correlate with values obtained by auscultation
using mercury cuff sphygmomanometer (r = 0.97 for
systolic pressure and r = 0.89 for diastolic pressure).13
An index of systemic vascular compliance was calculated
as: cardiac output/[heart rate2pulse pressure]. A good
correlation (r = 0.83) has been demonstrated between this
index and that derived by cardiac catheterisation.10 In
addition, segmental brachial artery distensibility was derived
from pressure waveform parameters, assuming a straight
tube brachial artery and T tube aortic system, as: brachial
arterial distensibility < 4p/(dP/dtpp2tpp), where dP/dtpp is
the amplitude from peak positive pressure derivative to the
peak negative pressure derivative, and tpp is the time interval
between positive and peak negative pressure derivatives.14
This approximation holds true as the brachial artery diameter
is much less than the cuff width. The systemic vascular
resistance was derived as mean blood pressure/cardiac
output.
To take into account both the steady and pulsatile
components of the arterial load, the effective arterial
elastance (Ea),
15 which is the ratio of LV end systolic pressure
to stroke volume, was calculated. The LV end systolic
pressure was approximated by the formula: [2 6 systolic
pressure + diastolic pressure]/3.16
Statistical analysis
Data are presented as mean (SD) unless otherwise stated.
Differences in demographic data, cardiac, and vascular
parameters between patients and controls were compared
using Student’s t test. Within the patient group, Pearson
correlation analysis was used to assess for possible relations
between serum ferritin concentration and various cardiovas-
cular indices. Stepwise multiple linear regression was used to
identify significant determinants of LV contractility.
Significance was defined as p , 0.05. All statistical analyses
were performed using SPSS Version 10.0 (SPSS, Inc, Chicago,
Illinois).
RESULTS
Patients
Thirty four patients (18 males) were studied at an age of 19.4
(6.6) years. Their haemoglobin was 13.9 (0.8) g/dl at the
time of study, while their average ferritin concentration
over the previous year was 5258 (2340) pmol/l. The demo-
graphic data and blood pressures of the patients and control
subjects are summarised in table 1. Thalassaemia patients
had significantly smaller body size (p , 0.05), lower systolic
blood pressure (p = 0.006), and smaller pulse pressure
(p , 0.001).
Vascular parameters
The cardiac and vascular parameters of patients and controls
are summarised in table 2. When compared with control
subjects, patients had significantly higher systemic vascular
resistance (p , 0.001), and hence a greater static vascular
load. The pulsatile vascular load was reflected by the indices
Table 1 Comparison of demographic data and blood
pressure between patients and controls
Patients
(n = 34)
Controls
(n = 34) p Value
Age (years) 19.4 (6.6) 19.7 (6.7) 0.86
Weight (kg) 41.5 (11) 53.3 (14.8) ,0.001*
Height (cm) 150 (13) 160 (13) 0.002*
Body mass index (kg/m2) 18.0 (2.5) 20.4 (3.8) 0.004*
Heart rate (beats/min) 79 (10) 81 (12) 0.62
Systolic BP (mm Hg) 104 (9) 112 (13) 0.006*
Diastolic BP (mm Hg) 69 (7) 68 (8) 0.65
Mean BP (mm Hg) 80 (8) 82 (9) 0.34
Pulse pressure (mm Hg) 45 (9) 57 (10) ,0.001*
*Denotes significance.
BP, blood pressure.
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Figure 1 Scatter plots showing (A) significant negative correlation
between systemic vascular compliance and pulse pressure (r = 20.56,
p , 0.001), and (B) similar negative correlation between brachial artery
distensibility and pulse pressure (r = 20.85, p , 0.001). The solid and
dashed lines represent linear regression of vascular compliance and
arterial distensibility on pulse pressure in patients (solid circles) and
control subjects (open circles), respectively.
770 Cheung, Ha, Chan
www.heartjnl.com
 on 8 November 2006 heart.bmj.comDownloaded from 
of systemic vascular compliance and brachial artery disten-
sibility. Given the significantly lower pulse pressure in
patients and the known inverse relation between pulse
pressure and vascular compliance and distensibility, adjust-
ments of the latter indices were required for meaningful
comparisons.14 After adjusting for the mean pulse pressure,14
patients were found to have significantly lower systemic
vascular compliance (p , 0.001) and brachial artery disten-
sibility (p = 0.001).
The systemic vascular compliance and brachial artery
distensibility were further analysed as a function of pulse
pressure (fig 1). While the slopes of the two regression lines
were similar (fig 1A, p = 0.55; fig 1B, p = 0.23), the
elevations were significantly different (fig 1A, p = 0.01;
fig 1B, p = 0.008), suggesting that while systemic vascular
compliance and brachial artery distensibility decreased with
an increase in pulse pressure in both groups, patients had
significantly lower vascular compliance and distensibility
throughout the range of pulse pressure.
The effective Ea was significantly greater in patients than
in controls (p = 0.001). This index correlated positively with
total vascular resistance (r = 0.69, p , 0.001) and nega-
tively with systemic vascular compliance (r = 20.32,
p = 0.008).
There was no significant correlation between serum ferritin
concentration and systemic vascular resistance (p = 0.42),
adjusted systemic vascular compliance (p = 0.10), or
adjusted brachial artery distensibility (p = 0.81).
Cardiac parameters
The cardiac and stroke volume indices were similar between
patients and controls (table 2). However, the LV+dP/dt was
significantly lower in patients than in controls (p = 0.001).
Multiple linear regression analysis of the entire cohort was
used to identify significant determinants of LV+dP/dt. The
dependent variables included were: age, sex, body mass
index, systolic and diastolic blood pressures, Ea, and patient
status. Significant determinants were age (standardised
b = 20.24, p = 0.003), body mass index (standardised
b = 20.34, p = 0.004), systolic blood pressure (standar-
dised b = 0.90, p , 0.001), and Ea (standardised
b = 20.50, p , 0.001) (model R2 = 0.69). In patients,
serum ferritin concentration did not correlate with either
the cardiac index (p = 0.30) or LV+dP/dt (p = 0.36).
When relating LV+dP/dt to Ea (fig 2), it became obvious
that the cardiovascular system in patients with b thalassae-
mia major was operating at a disadvantageous state, as
characterised by diminished cardiac contractility and
increased vascular load.
DISCUSSION
This study provides the first evidence of unfavourable
interactions between the heart and arterial system in patients
with b thalassaemia major. Albeit asymptomatic and with
normal LV shortening fraction on serial echocardiographic
evaluations, thalassaemia patients have significantly lower
LV+dP/dt that suggests LV contractile dysfunction.
Superimposed on this contractile abnormality is the increase
in static and pulsatile vascular load. Notably, the myocardial
contractility correlates inversely with the magnitude of the
vascular load.
The index of myocardial contractility used in the present
study was LV+dP/dt, as estimated from the arterial dP/dt.11 As
aforementioned, the method has been validated with
simultaneous measurements using invasive micromanometer
tipped catheters.12 Our findings of reduced LV+dP/dt in
thalassaemia patients corroborate those obtained in animal
models of chronic iron overload, which showed a dose
dependent decrease in LV+dP/dt in isolated perfused heart
preparations.17 18 While the exact mechanism whereby iron
interferes with cardiac function remains unclear, disruption
of intracellular calcium homeostasis19 and free radial
mechanisms18 20 have been implicated. The preservation of
LV fractional shortening, despite the changes in LV+dP/dt,
has likewise been observed in the animal model.17 This
discrepancy is probably related to the load sensitive nature of
the index of LV shortening fraction and the masking of
underlying contractile dysfunction as a result of the increase
in LV mass present in both iron overloaded patients6 and
animal models.17 Indeed, abnormal myocardial longitudinal
function has been demonstrated by Doppler tissue imaging in
thalassaemia patients whose conventional indices of global
systolic function are within normal.21
While cardiac dysfunction has been well documented in
patients with b thalassaemia major,1 2 dysfunction of the
arterial system, manifested as increased arterial stiffness and
endothelial dysfunction, has only recently been unveiled by
our group.6 The present findings in patients of a lower
systemic vascular compliance and brachial arterial distensi-
bility, using a different methodology, further confirm the
Table 2 Comparison of cardiac and vascular parameters between patients and controls
Patients (n = 34) Controls (n = 34) p Value
Cardiac index (l/min/m2) 3.13 (0.61) 3.24 (0.64) 0.48
Stroke volume index (ml/min/m2) 38.4 (3.2) 39.3 (3.8) 0.28
LV+dP/dt (mm Hg/s) 1059 (183) 1239 (237) 0.001*
Systemic vascular resistance (dynes/s/cm5) 1633 (259) 1377 (276) ,0.001*
Systemic vascular compliance, adjusted for mean pulse
pressure (ml/mm Hg)
1.21 (0.09) 1.37 (0.14) ,0.001*
Brachial artery distensbility, adjusted for mean pulse
pressure (%/mm Hg)
7.21 (1.29) 7.95 (0.29) ,0.001*
Effective Ea (mm Hg/ml) 1.86 (0.25) 1.65 (0.29) 0.001*
*Denotes significance.
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Figure 2 Unfavourable haemodynamic status of b thalassaemia
patients is characterised by reduced LV+dP/dt and increased effective Ea
(solid lines), as compared to healthy subjects (dashed lines). Error bars
represent mean (SD).
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results of our previous study.6 The resultant increase in
pulsatile arterial load may be attributable to structural
alterations in the arteries of thalassaemia patients7 8 and
increased vasomotor tone secondary to endothelial dysfunc-
tion.6
Additionally, systemic vascular resistance, the static
component of the vascular load, is also found to be increased
in our patients when assessed within the first 24 hours of
blood transfusion. This is in contrast to the previous findings
of a low systemic vascular resistance in patients studied just
before blood transfusion.22 23 Nonetheless, the concomitant
findings of increases in LV end systolic meridional and
circumferential wall stress, indices of the ventricular after-
load, in the previous studies are intriguing.22 23 Explanations
for the discrepant findings of a low systemic vascular
resistance and a high LV afterload have not, however, been
provided. Undoubtedly, patients with chronic anaemia have a
high cardiac output state caused by a low systemic vascular
resistance; this has been hypothesised to result from
vasodilation secondary to reduced inhibition of endothelium
derived relaxing factor by low circulating haemoglobin.24
Nonetheless, rapid normalisation of cardiac index and
systemic vascular resistance has been documented after
correction of severe chronic anaemia.24 Expectedly, the
cardiac index became normalised in our patients after blood
transfusion. It is intriguing, however, to find an elevated
systemic vascular resistance in the early post-transfusion
period, which, in conjunction with the increase in pulsatile
vascular load, may account for the higher LV afterload
observed in patients with b thalassaemia major. While the
exact cause remains unknown, arterial endothelial dysfunc-
tion may perhaps also explain the abnormally high systemic
vascular resistance that may otherwise have been masked
during the state of anaemia.
Hence, data from this and other studies22 23 suggest that
the LV afterload is chronically increased in patients with
b thalassaemia major, the magnitude of which may perhaps
be even higher in the early post-transfusion period. The
implications, in the light of the ventricular–arterial coupling
framework, are obvious.9 We have demonstrated that
effective Ea, an index of combined pulsatile and static load,
is a significant negative determinant of cardiac contractility.
Thus, patients with b thalassaemia major, albeit asympto-
matic, have disadvantageous cardiovascular haemodynamics
as characterised by impaired cardiac contractility and
increased vascular load. While the aetiology of myocardial
dysfunction cardiac function is multifactorial,4 the elevated
vascular load may jeopardise the cardiac function further
through suboptimal ventriculo-vascular coupling. Indeed,
afterload reduction with oral enalapril has been shown to
improve LV systolic and diastolic function in asymptomatic or
minimally symptomatic thalassaemia patients with LV
dysfunction.25
The finding of a low systolic blood pressure in thalassaemia
patients agrees with that reported previously.26 Proposed
explanations include a lower body mass index and reduced
sympathetic activity secondary to stimulation of thoracic
mechanoreceptors after blood transfusion.25 The latter may
perhaps also be envisaged as a compensatory mechanism for
the increase in vascular load.
Determination of ventriculo-arterial coupling within the
framework as advocated by Sunagawa and colleagues is not
feasible because of the non-invasive nature of the cardiovas-
cular assessment.15 27 Ideally, determination of the LV end
systolic pressure volume relation, Ea, and aortic input
impedance by invasive catheterisation studies will enable a
more accurate assessment of coupling efficiency and LV
afterload, respectively. Nonetheless, the results of the present
study do suggest that the interaction between the heart
and the arterial system is unfavourable in patients with
b thalassaemia major. Prophylactic vasodilator treatment in
clinically asymptomatic patients may perhaps delay the
deterioration of cardiac function in addition to iron chelation
therapy.
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Left ventricular pseudoaneurysm in a child
A
14 year old girl presented with a
history of fatigue, atypical chest
pain, and breathlessness for one
month. Her haemoglobin was 8.3 g/dl
and erythrocyte sedimentation rate
(ESR) was 48 mm in the first hour.
She had an anterolateral myocardial
infarction on ECG. Her echocardiogram
revealed a large pseudoaneurysm of the
mid and apical lateral left ventricular
free wall. On cardiac catheterisation, the
presence of large anterolateral left ven-
tricular pseudoaneurysm was confirmed
(panel A). It also showed constriction of
the aortic arch, with a gradient of
30 mm Hg across it, ectatic changes in
arch vessels, and diffuse irregularity of
the descending thoracic and abdominal
aorta (panel B). Coronary angiogram
revealed distal left anterior descending
artery occlusion. The patient was diag-
nosed as having active non-specific
aortoarteritis with involvement of
coronary arteries with myocardial
infarction. She underwent resection of
the pseudoaneurysm and was started on
steroids. The resected tissue revealed
ischaemic changes. She was doing well
at three month follow up.
S S Kothari, A Roy, G Sharma
kotharis@vsnl.net.in
Left ventriculogram in right anterior oblique
position showing presence of a large
anterolateral pseudoaneurysm.
Aortogram showing diffuse irregularity of the
descending thoracic aorta and upper
abdominal aorta.
doi: 10.1136/hrt.2004.049221
A vascular ring without compression: double aortic arch presenting as a coincidental finding during
cardiac catheterisation
W
e present a case of a 73 year old woman with double
aortic arch and separate origin of the right common
carotid and right subclavian arteries, found coin-
cidentally during cardiac angiography. She has a history of
coronary artery disease and atherosclerotic renal artery
occlusion. Medical history includes indigestion (relieved by
proton pump inhibition), deep vein thrombosis, pulmonary
embolic disease, coronary bypass grafting, and a minor
stroke. The image (three dimensional reconstructed magnetic
resonance contrast angiography) demonstrates the double
aortic arch. The right common carotid and right subclavian
arteries arise separately from the posterior arch and the left
common carotid and left subclavian from the anterior arch.
The right and left vertebral arteries arise from the corre-
sponding subclavian arteries. The right vertebral artery is
stenotic and shows post-stenotic dilatation. Both aortic
lumina are similar in calibre and intact. There was no
dysphagia or stridor and there was no tracheal compression
identified on native images. This observation suggests that
the incidence and prevalence of this rare condition may be
underestimated.
H Kindler
J P Bagger
P Tait
P G Camici
heiko.kindler@imperial.ac.uk
Ao, aorta; LCC, left common carotid; LSA, left subclavian artery; LVA,
left vertebral artery; RCC, right common carotid; RSA, right subclavian
artery; RVA, right vertebral artery.
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